The Polypill: From Promise to Pragmatism.
Mark Huffman asks what happened to the polypill to reduce cardiovascular risk, explores the promise it still holds, and considers how best to turn promise into reality.
Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.
Mark D
MD
Huffman
D002317:Cardiovascular Agents / Q000008:administration & dosage*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D006801:Humans; D055118:Medication Adherence; D011322:Primary Prevention; D055502:Secondary Prevention / Q000379:methods*; D014481:United States; D014486:United States Food and Drug Administration
D002317:Cardiovascular Agents